Evaluation of a mathematical model of rat body weight regulation in application to caloric restriction and drug treatment studies

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Selimkhanov, Jangir ^a   Thompson, W Clayton ^a   Patterson, Terrell A ^a   Hadcock, John R ^a,b   Scott, Dennis O ^a   Maurer, Tristan S ^a   Musante, Cynthia J ^a  

^a PFIZER INC   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR ANTAGONIST; RIMONABANT; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CALORIC RESTRICTION; CONTROLLED STUDY; DRUG DESIGN; DRUG DEVELOPMENT; DRUG THERAPY; ENERGY BALANCE; FAT FREE MASS; MALE; MATHEMATICAL MODEL; METABOLISM; MOUSE; NONHUMAN; RAT; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; WEIGHT CHANGE; ANIMAL; ANTAGONISTS AND INHIBITORS; CALORIC INTAKE; DRUG EFFECTS; ENERGY METABOLISM; EVALUATION STUDY; PHYSIOLOGY; THEORETICAL MODEL;

ANIMALS; BODY COMPOSITION; BODY WEIGHT; CALORIC RESTRICTION; CANNABINOID RECEPTOR ANTAGONISTS; ENERGY INTAKE; ENERGY METABOLISM; MALE; MODELS, THEORETICAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1;

EID: 84973472638     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155674     Document Type: Article

References (29)

1. Williams EP, Mesidor M, Winters K, Dubbert PM, Wyatt SB. Overweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health Problem. Current Obesity Reports. 2015; 4 (3):363-370. doi: 10.1007/s13679-015-0169-4 PMID: 26627494
2. Wu T, Gao X, Chen M, Van Dam R. Long-term effectiveness of diet-plus-exercise interventions vs. dietonly interventions for weight loss: a meta-analysis. Obesity reviews. 2009; 10(3):313-323. doi: 10.1111/j.1467-789X.2008.00547.x PMID: 19175510
3. Smoliga JM, Vang O, Baur JA. Challenges of translating basic research into therapeutics: resveratrol as an example. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2012; 67(2):158-167. doi: 10.1093/gerona/glr062
4. Rodgers RJ, Tschöp MH, Wilding JP. Anti-obesity drugs: past, present and future. Disease models & mechanisms. 2012; 5(5):621-626. doi: 10.1242/dmm.009621
5. Valsamakis G, Lois K, Kumar S, Mastorakos G. New molecular targets in the pathophysiology of obesity and available treatment options under investigation. Clinical obesity. 2014; 4(4):209-219. PMID: 25826792
6. Hall KD. Predicting metabolic adaptation, body weight change, and energy intake in humans. American Journal of Physiology-Endocrinology and Metabolism. 2010; 298(3):E449-E466. doi: 10.1152/ajpendo.00559.2009 PMID: 19934407
7. Guo J, Hall KD. Estimating the continuous-time dynamics of energy and fat metabolism in mice. PLoS computational biology. 2009; 5(9):e1000511. doi: 10.1371/journal.pcbi.1000511 PMID: 19763167
8. Guo J, Hall KD. Predicting changes of body weight, body fat, energy expenditure and metabolic fuel selection in C57BL/6 mice. PLoS One. 2011; 6(1):e15961. doi: 10.1371/journal.pone.0015961 PMID: 21246038
9. Gennemark P, Jansson-Löfmark R, Hyberg G, Wigstrand M, Kakol-Palm D, Håkansson P, et al. A modeling approach for compounds affecting body composition. Journal of pharmacokinetics and pharmacodynamics. 2013; 40(6):651-667. doi: 10.1007/s10928-013-9337-x PMID: 24158456
10. Gennemark P, Hjorth S, Gabrielsson J. Modeling energy intake by adding homeostatic feedback and drug intervention. Journal of pharmacokinetics and pharmacodynamics. 2015; 42(1):79-96. doi: 10.1007/s10928-014-9399-4 PMID: 25388764
11. Jacquier M, Crauste F, Soulage CO, Soula HA. A Predictive Model of the Dynamics of Body Weight and Food Intake in Rats Submitted to Caloric Restrictions. PLoS ONE. 2014 Jun; 9(6):e100073. doi: 10.1371/journal.pone.0100073 PMID: 24932616
12. Sam AH, Salem V, Ghatei MA Rimonabant: from RIO to ban. Journal of Obesity. 2011 May; 2011: ID432607 doi: 10.1155/2011/432607
13. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. The Lancet. 2007; 370(9600):1706-1713. doi: 10.1016/S0140-6736(07)61721-8
14. Colombo G, Agabio R, Diaz G, Lobina C, Reali R, Gessa GL. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life sciences. 1998; 63(8):PL113-PL117. doi: 10.1016/S0024-3205(98)00322-1 PMID: 9718088
15. Thornton-Jones ZD, Kennett GA, Benwell KR, Revell DF, Misra A, Sellwood DM, et al. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake. Pharmacology Biochemistry and Behavior. 2006 Jun; 84(2):353-359. doi: 10.1016/j.pbb.2006.06.001
16. Poirier B, Bidouard JP, Cadrouvele C, Marniquet X, Staels B, O'connor S, et al. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes, Obesity and Metabolism. 2005; 7(1):65-72. doi: 10.1111/j.1463-1326.2004.00374.x PMID: 15642077
17. Doyon C, Denis RG, Baraboi ED, Samson P, Lalonde J, Deshaies Y, et al. Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats. Diabetes. 2006; 55(12):3403-3410. doi: 10.2337/db06-0504 PMID: 17130486
18. Herling AW, Kilp S, Elvert R, Haschke G, Kramer W. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats. Endocrinology. 2008; 149(5):2557-2566. doi: 10.1210/en.2007-1515 PMID: 18276749
19. Abstracts of the 2nd Asian Pacific Regional ISSX Meeting (May 11-13, 2008). Drug Metabolism Reviews. 2008; 40:Sup2:1-226.
20. Chow CC, Hall KD. The dynamics of human body weight change. PLoS Comput Biol. 2008; 4(3): e1000045. doi: 10.1371/journal.pcbi.1000045 PMID: 18369435
21. Hall KD. Mathematical modeling of energy expenditure during tissue deposition. British journal of nutrition. 2010; 104(01):4-7. doi: 10.1017/S0007114510000206 PMID: 20132585
22. Petráš I, Bednárová D. Total least squares approach to modeling: a Matlab toolbox. Acta Montanistica Slovaca. 2010; 15(2):158.
23. Thompson WC, Zhou Y, Tulukdar S, Musante CJ. PF-05231023, a Long-Acting FGF21 Analogue, Decreases Body Weight by Reduction of Food Intake in Non-Human Primates. submitted 2016.
24. Heymsfield S, Gonzalez M, Shen W, Redman L, Thomas D. Weight loss composition is one-fourth fatfree mass: a critical review and critique of this widely cited rule. Obesity Reviews. 2014; 15(4):310-321. doi: 10.1111/obr.12143 PMID: 24447775
25. Forbes GB. Lean Body Mass-Body Fat Interrelationships in Humans. Nutrition reviews. 1987; 45 (10):225-231. doi: 10.1111/j.1753-4887.1987.tb02684.x PMID: 3306482
26. Careau V, Thomas D, Humphries M, Réale D. Energy metabolism and animal personality. Oikos. 2008; 117(5):641-653. doi: 10.1111/j.0030-1299.2008.16513.x
27. Kalliokoski O, Jacobsen KR, Darusman HS, Henriksen T, Weimann A, Poulsen HE, et al. Mice do not habituate to metabolism cage housing - a three week study of male BALB/c mice. PloS one. 2013; 8 (3):e58460. doi: 10.1371/journal.pone.0058460 PMID: 23505511
28. Dicker S. Changes in the extracellular and intracellular fluid phases of muscle during starvation and dehydration in adult rats. Biochemical Journal. 1949; 44(3):274. doi: 10.1042/bj0440274 PMID: 16748515
29. Morrison S, Mackay C, Hurlbrink E, Wier JK, Nick MS, Millar FK. The water exchange and polyuria of rats deprived of food. Quarterly Journal of Experimental Physiology and Cognate Medical Sciences. 1967; 52(1):51-67. doi: 10.1113/expphysiol.1967.sp001885